Retatrutide 10mg

Retatrutide 10mg | Triple Agonist Research Peptide

Retatrutide (LY3437943) is a next-generation triple receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. Each vial contains 10mg of lyophilized Retatrutide, produced to exacting standards of purity and integrity for advanced metabolic research.

Key Research Attributes

• Classification: GLP-1 / GIP / Glucagon Triple Agonist
• Form: Lyophilized powder
• Quantity: 10mg per vial
• Purity: ≥99%
• Storage: Lyophilized at -20°C; stable for extended periods

Research Applications

• Metabolic syndrome and obesity mechanism studies
• Incretin hormone pathway research
• Glucagon receptor modulation investigations
• Comparative efficacy studies vs. GLP-1 mono-agonists

For research purposes only. Not intended for human consumption. Must be handled by qualified researchers in a controlled laboratory environment.